BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.87B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$2.2B |
| 3 |
Amazon
AMZN
|
+$1.9B |
| 4 |
NVIDIA
NVDA
|
+$1.86B |
| 5 |
Costco
COST
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.53B |
| 2 |
SPLK
Splunk Inc
SPLK
|
+$1.81B |
| 3 |
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
|
+$732M |
| 4 |
Super Micro Computer
SMCI
|
+$728M |
| 5 |
IMGN
Immunogen Inc
IMGN
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.8% |
| 2 | Healthcare | 12.59% |
| 3 | Financials | 12.24% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Industrials | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ADVM
3601
DELISTED
Adverum Biotechnologies
ADVM
| $4.47M | ﹤0.01% |
316,450
+176,332
| +126% | +$2.68M |
|
3602
Byrna Technologies
BYRN
$97.6M
| $4.46M | ﹤0.01% |
320,045
+30,926
| +11% | +$300K |
|
|
CONN
3603
DELISTED
Conn's Inc.
CONN
| $4.43M | ﹤0.01% |
1,322,027
-300,629
| -19% | -$1.29M |
|
3604
Smartbird Inc
BIRD
$31.2M
| $4.4M | ﹤0.01% |
316,759
-13,411
| -4% | -$250K |
|
3605
Consumer Portfolio Services
CPSS
$208M
| $4.37M | ﹤0.01% |
578,585
-20,092
| -3% | -$171K |
|
|
CNTA
3606
DELISTED
Centessa Pharmaceuticals
CNTA
| $4.32M | ﹤0.01% |
382,462
+36,191
| +10% | +$343K |
|
|
SHCO
3607
DELISTED
Soho House & Co
SHCO
| $4.32M | ﹤0.01% |
761,888
-12,184
| -2% | -$73.7K |
|
3608
iShares GNMA Bond ETF
GNMA
$433M
| $4.32M | ﹤0.01% |
99,545
-4,664
| -4% | -$203K |
|
3609
Alto Ingredients
ALTO
$326M
| $4.3M | ﹤0.01% |
1,970,613
-283,359
| -13% | -$597K |
|
|
EXAI
3610
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $4.29M | ﹤0.01% |
750,508
+96,680
| +15% | +$601K |
|
3611
The Honest Company
HNST
$540M
| $4.28M | ﹤0.01% |
1,057,620
-54,515
| -5% | -$184K |
|
3612
State Street SPDR S&P Dividend ETF
SDY
$22.2B
| $4.26M | ﹤0.01% |
32,492
-328
| -1% | -$41.1K |
|
3613
Cue Biopharma
CUE
$131M
| $4.24M | ﹤0.01% |
74,803
-3,156
| -4% | -$223K |
|
3614
TFI International
TFII
$12.1B
| $4.21M | ﹤0.01% |
26,395
+3,193
| +14% | +$457K |
|
3615
Hagerty
HGTY
$1.32B
| $4.19M | ﹤0.01% |
457,829
-2,100
| -0.5% | -$17.6K |
|
|
ORGN
3616
DELISTED
Origin Materials
ORGN
| $4.18M | ﹤0.01% |
273,049
-10,098
| -4% | -$175K |
|
3617
Protalix BioTherapeutics
PLX
$190M
| $4.17M | ﹤0.01% |
3,310,517
-147,217
| -4% | -$220K |
|
|
KZR
3618
DELISTED
Kezar Life Sciences
KZR
| $4.16M | ﹤0.01% |
461,699
-20,028
| -4% | -$182K |
|
3619
Ramaco Resources Class B
METCB
$406M
| $4.12M | ﹤0.01% |
354,433
-15,428
| -4% | -$177K |
|
3620
Solid Biosciences
SLDB
$974M
| $4.09M | ﹤0.01% |
307,066
+192,968
| +169% | +$1.81M |
|
3621
ESS Tech
GWH
$19.6M
| $4.08M | ﹤0.01% |
375,961
-18,877
| -5% | -$257K |
|
|
SA
3622
Seabridge Gold
SA
$3.46B
| $4.07M | ﹤0.01% |
269,021
+2,012
| +0.8% | +$23.4K |
|
3623
Angi Inc
ANGI
$196M
| $4.06M | ﹤0.01% |
154,871
+1,026
| +0.7% | +$26.1K |
|
3624
Brookfield
BN
$111B
| $4.04M | ﹤0.01% |
144,611
+29,922
| +26% | +$807K |
|
3625
NET Power
NPWR
$143M
| $4.01M | ﹤0.01% |
352,014
-10,737
| -3% | -$97.2K |
|
Similar funds
BlackRock's Q1 2024 Portfolio in Review
As of Q1 2024, BlackRock held 5,499 positions worth $4.3T, up 9.5% from $3.92T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
BlackRock's Q1 2024 filing shows 129 new, 1,833 increased, 2,801 reduced and 210 closed positions. Its largest new stake was Arcadium Lithium plc: 122,471,992 shares worth $528M. The largest sale was iShares Core S&P 500 ETF, an estimated $2.53B.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q1 2024 buy was Arcadium Lithium plc: 122,471,992 shares worth $528M.
- BlackRock added most to Microsoft in Q1 2024, an estimated $2.87B increase.
- BlackRock's biggest Q1 2024 reduction was iShares Core S&P 500 ETF, cutting an estimated $2.53B.
- BlackRock fully exited Splunk Inc in Q1 2024, selling an estimated $1.81B.
- BlackRock's ten largest holdings make up 24% of its $4.3T portfolio in Q1 2024.
- BlackRock opened 129 new positions and closed 210 in Q1 2024.
- BlackRock's portfolio value rose 9.5% quarter-over-quarter to $4.3T.
Based on BlackRock's 13F filing for Q1 2024, filed 10 May 2024.